Low-dose CT screening and follow-up adherence was poor among patients with Lung-RADS negative (21.3%) and positive (28.6%) results, with age, race, smoking, and COPD influencing adherence.
Cohort (n=25,516)
Yes
What factors are associated with adherence to CT screening and follow-up across Lung-RADS negative and positive categories in adults aged 55-74?
Adherence to lung cancer screening and follow-up is poor in real-world practice, highlighting the need for targeted strategies addressing age, race, smoking, COPD, and frailty.
Absolute Event Rate: 21.3% vs 28.6%
Abstract Background: Timely screening and follow-up care are critical for reducing lung cancer mortality. However, adherence to low-dose computed tomography (LDCT) or any CT screening and guideline-recommended follow-up remains poor in real-world practice after the baseline scan. The objective of this study is to identify factors associated with adherence across Lung-RADS negative and positive categories. Methods: We conducted a retrospective, multi-site cohort study of adults aged 55-74 who underwent LDCT between 2016 and 2020, had ≥1 primary care visit before baseline, and had no lung cancer diagnosis in the prior 5 years. Adherence definitions followed Lung-RADS management guidelines. We fit mixed-effects logistic regression models with a random intercept for site, estimated using adaptive Gauss-Hermite quadrature (QPOINTS=7). Results: Of 31, 795 patients, 6279 were excluded, leaving 21, 275 Lung-RADS negative (1-2) and 4, 241 Lung-RADS positive (3-4X) patients. Adherence was low in both groups: 21. 3% for Lung-RADS 1-2 and 28. 6% for Lung-RADS 3-4X. Among Lung-RADS 1-2 patients, adherence was higher among those aged ≥65 (OR 1. 19; 95% CI 1. 10-1. 28) compared with 65 years, and those with COPD (OR 1. 15; 95% CI 1. 06-1. 24), but lower among Black patients compared with White patients (OR 0. 87; 95% CI 0. 78-0. 96) and never smokers compared with current smokers (OR 0. 65; 95% CI 0. 53-0. 79). Among Lung-RADS 3-4X patients, COPD remained positively associated with adherence (OR 1. 19; 95% CI 1. 03-1. 39), while pre-frailty was associated with lower adherence compared with non-frail status (OR 0. 80; 95% CI 0. 66-0. 98). Most other sociodemographic and contextual factors were not statistically significant in adjusted models. Conclusions: Adherence to any CT screening after negative results and recommended follow-up after positive findings remains poor. Age, race, smoking behavior, COPD, and frailty-related vulnerability contribute to adherence patterns, highlighting the need for targeted, patient-centered strategies to improve retention and follow-up in real-world screening programs. Keywords: Lung-RADS, adherence, follow-up, lung cancer Citation Format: Pratibha Shrestha, Michael K. Gould, Xiangyang Lou, Gerard A. Silvestri, Dejana Braithwaite, Shama D. Karanth. Adherence to CT screening and follow-up by Lung-RADS category: A multicenter cohort study abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts) ; 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86 (8Suppl): Abstract nr LB394.
Shrestha et al. (Fri,) conducted a cohort in Lung cancer screening (n=25,516). Low-dose computed tomography (LDCT) screening was evaluated on Adherence to CT screening and guideline-recommended follow-up. Low-dose CT screening and follow-up adherence was poor among patients with Lung-RADS negative (21.3%) and positive (28.6%) results, with age, race, smoking, and COPD influencing adherence.